Rosetta Genomics completes direct offering;
Rosetta Genomics Ltd. announced that it has completed registered direct offering with several institutional investors of approximately $5.1 million of securities.
Microsoft on Monday said it has agreed to buy certain assets of Rosetta Biosoftware, a provider of informatics solutions for life science research.